AGP Picks
View all

HHS announces funding for development of PTSD treatment, study on emerging mental illness remedies

News originally published by

American Hospital Association

The Department of Health and Human Services Nov. 12 made two announcements  regarding the development of mental health treatments for veterans and other individuals. The agency announced it would fund up to $4.9 million through the Advanced Research Projects Agency for Health to advance the development of ibogaine as a potential treatment for post-traumatic stress disorder and other serious mental illnesses for veterans and others. HHS also announced that the National Institute of Mental Health issued a funding notice of $20 million to support the development of a research network to study rapid-acting psychotropic interventional drugs, such as ketamine, esketamine, psilocybin and other emerging treatments for serious mental illnesses. The agency said award recipients will be announced in the summer of 2027.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.